TrialScope to Present at 2nd Disclosure and Transparency for Clinical Data Summit


June 19, 2020

Chief Strategy Officer to speak to trial sponsors on how to navigate the complexities of disclosing global trial data on EU CTR

Jersey City, NJ – Aug. 3, 2018 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that its Chief Strategy Officer, Thomas Wicks, will be presenting at the 2nd Disclosure and Transparency for Clinical Data Summit on August 13th at 11:15 a.m. EDT in Philadelphia, Pennsylvania. The presentation, titled, “Fixing the Compliance Challenge on EU CTR,” will provide clinical trial sponsors with insight to understand the regulatory requirements for disclosing results of clinical trials on the EU Clinical Trials Register (CTR), assess their company’s compliance and address potential issues.

Disclosing trials results can be complex, especially with more than 40 registries and over 90 countries with regulations. In his session focused on the EU CTR, Wicks will help trial sponsors:

  • Understand the scope of the compliance challenge
  • Identify the trials their organizations are responsible for
  • Correct the record

“The global regulatory environment is constantly changing, and with various registries for filing clinical trial data – such as EU CTR – sponsors need to be aware of the steps to take to mitigate any risk,” said Wicks. “I’m hoping that sponsors will walk away from this session with a better understanding of how to disclose their trials on EU CTR and on a global scale more efficiently.”

In addition to Wicks’ session, Francine Lane, VP of Global Transparency at TrialScope, will be participating in a panel discussion titled, “Infrastructural Issues with Data Transparency.” That session will be taking place on Monday, August 13th at 2:00p.m. EDT.

For more information on the 2nd Disclosure and Transparency for Clinical Data Summit Conference, and the full agenda, visit:

About TrialScope 

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors and over 40% of all industry trials registered on and EudtraCT. TrialScope provides proven solutions that are designed to optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit

The post TrialScope to Present at 2nd Disclosure and Transparency for Clinical Data Summit appeared first on TrialScope.